| Authors: |
Riano I; Division of Hematology and Medical Oncology, Dartmouth Cancer Center, Dartmouth Health, Geisel School of Medicine at Dartmouth, Lebanon, NH., Velez MA; Department of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, CA., Pomares-Millan H; Department of Epidemiology, Dartmouth Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH., Blaquier J; Service of Neuro-Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Peshin S; Department of Internal Medicine, Norton Community Hospital, Norton, VA., Feldman J; EGFR Resisters, Chicago, IL., Velazquez AI; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA. Electronic address: ana.velazquezmanana@ucsf.edu. |
